FDA drafts AI-enabled medical device lifecycle plan guidance

The Food and Drug Administration announced the availability of draft guidance that provides recommendations on lifecycle controls in submissions to market machine learning-enabled device software functions.

WHY IT MATTERS

In the “Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning-Enabled Device Software Functions,” the FDA proposes to ensure that AI/ML-enabled devices…